GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Alexion Pharmaceuticals, Inc. (ALXN) [hlAlert]

Rating:
Buy ALXN
up 819.56 %

Alexion Pharmaceuticals, Inc. (ALXN) rated Buy

Posted on: Friday,  Oct 26, 2007  9:25 AM ET by Broadpoint Capital

Broadpoint Capital rated Buy Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) on 10/26/2007, when the stock price was $19.56. Since
then, Alexion Pharmaceuticals, Inc. has gained 819.56% as of 12/11/2015's recent price of $179.82.
If you would have followed this Broadpoint Capital's recommendation on ALXN, you would have gained 819.56% of your investment in 2968 days.

Alexion Pharmaceuticals develops pharmaceutical products for the treatment of heart disease, and inflammation, diseases of the immune system and cancer in humans. The company's lead product candidates are genetically altered antibodies that target specific diseases which arise when the human immune system induces undesired inflammation in the human body. These candidates are designed to block components of the human immune system which cause undesired inflammation while allowing beneficial components of the immune system to remain functional.

Broadpoint Capital, Inc. is an investment banking and capital markets firm that provides corporate and public finance services and trading of corporate, government, and municipal securities for institutions. The company has three divisions: Municipal Capital Markets division, which underwrites and trades municipal securities in new issue and secondary markets; Taxable Fixed Income division, which is a dealer focusing on fixed income securities with limited liquidity; and Equity Capital Markets division, which is a sector-focused investment banking group providing research, trading, raising of capital and advisory services for institutional and corporate clients. Broadpoint Capital, formerly known as First Albany Corporation, was founded in 1953 and is based in New York, New York. The company operates as a subsidiary of First Albany Companies Inc.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
10/26/2007 9:25 AM Buy
None
19.56 21.50
as of 8/27/2015
1 Week down  -5.16 %
1 Month down  -5.81 %
3 Months up  11.21 %
1 YTD up  35.32 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy